Regis Healthcare (ASX:REG) Cash Flow from Financing: A$-51 Mil (TTM As of Dec. 2025)


ASX:REG Regis Healthcare Ltd ASX:REG
84 GF Score
Price A$6.74
GF Value A$10.54
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Regis Healthcare Cash Flow from Financing?

Regis Healthcare ASX:REG +0.30% 84 Cash Flow from Financing is A$-51 Mil as of Dec. 2025. GuruFocus rates ASX:REG with a GF Score™ of 84/100 and a GF Value™ of A$10.54 (Possible Value Trap). The stock has 4 warning signs investors should review.

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the six months ended in Dec. 2025, Regis Healthcare paid A$0 Mil more to buy back shares than it received from issuing new shares. It received A$0 Mil from issuing more debt. It paid A$0 Mil more to buy back preferred shares than it received from issuing preferred shares. It spent A$24 Mil paying cash dividends to shareholders. It spent A$1 Mil on other financial activities. In all, Regis Healthcare spent A$25 Mil on financial activities for the six months ended in Dec. 2025.


Regis Healthcare  (ASX:REG) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Regis Healthcare's issuance of stock for the six months ended in Dec. 2025 was A$0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Regis Healthcare's repurchase of stock for the six months ended in Dec. 2025 was A$0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Regis Healthcare's net issuance of debt for the six months ended in Dec. 2025 was A$0 Mil. Regis Healthcare received A$0 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Regis Healthcare's net issuance of preferred for the six months ended in Dec. 2025 was A$0 Mil. Regis Healthcare paid A$0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Regis Healthcare's cash flow for dividends for the six months ended in Dec. 2025 was A$-24 Mil. Regis Healthcare spent A$24 Mil paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Regis Healthcare's other financing for the six months ended in Dec. 2025 was A$-1 Mil. Regis Healthcare spent A$1 Mil on other financial activities.


Regis Healthcare Cash Flow from Financing Related Terms


Regis Healthcare Cash Flow from Financing Historical Data

* Premium members only.

The historical data trend for Regis Healthcare's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regis Healthcare Cash Flow from Financing Chart

Regis Healthcare Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -119.48 -62.39 -43.17 -112.12 -45.82

Regis Healthcare Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -21.01 -91.11 -20.63 -25.19 -25.35
ASX:REG
84GF Score
Regis Healthcare Ltd ASX:REG
Cash Flow from Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Regis Healthcare Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Regis Healthcare's Cash from Financing for the fiscal year that ended in Jun. 2025 is calculated as:

Regis Healthcare's Cash from Financing for the quarter that ended in Dec. 2025 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-51 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow from Financing of A$-51 Mil mean?
Regis Healthcare (ASX:REG) has a Cash Flow from Financing of A$-51 Mil as of Dec. 2025. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Regis Healthcare and its competitors.
Is Regis Healthcare's Cash Flow from Financing too high?
Regis Healthcare's current Cash Flow from Financing is A$-51 Mil. Overall, Regis Healthcare has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Regis Healthcare's Cash Flow from Financing compare to HCA and THC?
Regis Healthcare's Cash Flow from Financing of A$-51 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Financing for a Healthcare Providers & Services company?
A good Cash Flow from Financing depends on the Healthcare Providers & Services industry context. However, Cash Flow from Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Financing mean?
A high Cash Flow from Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Regis Healthcare and its competitors. Regis Healthcare's current Cash Flow from Financing is A$-51 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regis Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Regis Healthcare (ASX:REG) is currently considered Possible Value Trap. The stock's GF Value™ is A$10.54, compared to a current price of A$6.74 — trading 36.1% below its estimated fair value. The current Cash Flow from Financing is A$-51 Mil. Regis Healthcare's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Financing calculated?
Cash Flow from Financing is calculated from a company's financial statements. For Regis Healthcare (ASX:REG), the current Cash Flow from Financing is A$-51 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Regis Healthcare (ASX:REG) Overvalued in 2026?

Based on GuruFocus' analysis, Regis Healthcare stock appears to be undervalued. The current stock price of A$6.74 is trading 36.1% below its estimated GF Value™ of A$10.54. GuruFocus considers Regis Healthcare to be Possible Value Trap.

Key valuation signals for ASX:REG:

  • Cash Flow from Financing: A$-51 Mil
  • GF Value™: A$10.54 vs. price of A$6.74 (36.1% below fair value)
  • GF Score™: 84/100 with 4 warning signs

No single metric tells the full story. See the ASX:REG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Regis Healthcare Business Description

Other Exchanges 06K1:Germany
Address 293 Camberwell Road, Level 2, Camberwell, Melbourne, VIC, AUS, 3124
Regis Healthcare is an Australian residential aged care operator providing accommodation and care for individuals who require high levels of support due to health or mobility issues. Residents are typically over 85 years old and are typified by dementia, palliative care, incontinence, and falls risk. Regis also operates smaller retirement village and home care businesses.
84GF Score

Get the complete analysis for ASX:REG

Cash Flow from Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$6.74
Price
A$10.54
GF Value